Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.2 - $0.5 $17,756 - $44,391
-88,783 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.41 - $0.63 $4,318 - $6,636
-10,534 Reduced 10.61%
88,783 $49,000
Q4 2021

Feb 11, 2022

BUY
$0.57 - $1.29 $2,994 - $6,777
5,254 Added 5.59%
99,317 $58,000
Q3 2021

Nov 04, 2021

SELL
$1.11 - $1.7 $3,357 - $5,142
-3,025 Reduced 3.12%
94,063 $116,000
Q2 2021

Aug 11, 2021

BUY
$1.46 - $2.25 $141,748 - $218,448
97,088 New
97,088 $164,000
Q1 2020

May 14, 2020

SELL
$0.56 - $0.97 $17,516 - $30,341
-31,280 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$0.62 - $1.06 $555 - $949
-896 Reduced 2.78%
31,280 $26,000
Q3 2019

Nov 14, 2019

BUY
$0.81 - $1.06 $26,062 - $34,106
32,176 New
32,176 $31,000
Q4 2018

Feb 14, 2019

SELL
$0.39 - $3.47 $26,871 - $239,083
-68,900 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.39 - $2.25 $34,231 - $55,410
24,627 Added 55.63%
68,900 $146,000
Q2 2018

Apr 21, 2020

BUY
$1.44 - $2.24 $30,528 - $47,488
21,200 Added 91.88%
44,273 $64,000
Q2 2018

Aug 14, 2018

SELL
$1.44 - $2.24 $111,415 - $173,313
-77,372 Reduced 77.03%
23,073 $33,000
Q1 2018

Oct 18, 2019

BUY
$1.51 - $2.06 $50,666 - $69,121
33,554 Added 50.16%
100,445 $164,000
Q1 2018

May 15, 2018

SELL
$1.51 - $2.06 $95,993 - $130,958
-63,572 Reduced 48.73%
66,891 $108,000
Q4 2017

Feb 14, 2018

SELL
$1.4 - $2.6 $91,443 - $169,824
-65,317 Reduced 33.36%
130,463 $208,000
Q3 2017

Nov 14, 2017

BUY
$2.22 - $2.79 $434,631 - $546,226
195,780
195,780 $497,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.